“Immunologic dream team”: BiTEs periallotransplant to redirect donor lymphocytes toward GVL
Lorenzo Iovino, Mazyar Shadman, Filippo Milano, Ajay K. Gopal · 2026
Read “Immunologic dream team”: BiTEs periallotransplant to redirect donor lymphocytes toward GVL by Lorenzo Iovino, Mazyar Shadman, Filippo Milano, Ajay K. Gopal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13446305.txt.
Description
Iovino and colleagues argue for combining two immunotherapies that each fail on their own. Their 2026 commentary discusses bispecific T-cell engagers, or BiTEs. These antibody-like drugs drag T cells onto tumour cells. The authors pair them with donor stem cell transplant, which can cure blood cancers through the graft-versus-tumour effect. Both approaches lose effectiveness over time in many patients.
The authors review why. BiTEs depend on the patient's own worn-down T cells, which heavy pretreatment leaves exhausted, while transplant relapse remains common, especially when disease is not fully cleared beforehand. Their proposal is to give BiTEs around the transplant window, redirecting fresh donor lymphocytes against the cancer instead. They frame donor cells as an immunologic dream team for the engagers: unexhausted, abundant, and already primed to attack. The piece maps the rationale and obstacles for trials of this combination.
Catalog record
| CREATOR | Lorenzo Iovino, Mazyar Shadman, Filippo Milano, Ajay K. Gopal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |